MondayNightIBD | GETECCU X MNIBD Case Convo | March 27, 2023 | Vicent Hernandez, MD, PhD
*Pre-assessment*

Before you participate in this activity, please take this pre-assessment. Taking this pre-assessment does not immediately qualify learners to earn credit. 

Certificates of credit will only be sent to learners who also receive a passing score on the post-test (separate from this survey), and fill out the evaluation form and application for credit.
1.Where are you in your career? (Required.)
2.A 52-year-old woman diagnosed with Crohn’s disease A2L1+4B2-3, former smoker. Jejunal resection at 31 years because of stricturing disease. She was started on adalimumab at 49 years, but she developed a new fistula arising the from terminal ileum to the psoas at 52 years. An ileocecal resection with Kono-S anastomosis was performed.

In addition to starting effective therapy, which one is true regarding post-operative recurrence:
(Required.)
3.A 52-year-old woman diagnosed with Crohn’s disease A2L1+4B2-3, former smoker. Jejunal resection at 31 years because of stricturing disease. She was started on adalimumab at 49 years, but she developed a new fistula arising the from terminal ileum to the psoas at 52 years. An ileocecal resection with Kono-S anastomosis was performed.

With respect to the pharmacological treatment to prevent postoperative recurrence:
(Required.)
4.Please let us know who you are so we can connect your responses to your post-test & application to claim CME credit (completed after participating in the activity) 
Privacy & Cookie Notice